Status:
COMPLETED
A Phase II Trial of CyberKnife Radiosurgery to Perioptic Tumors
Lead Sponsor:
Community Cancer Center, Normal, Illinois
Conditions:
Tumor, Benign, Optic Nerve
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The purpose of this study is to find out what effects (good and bad) CyberKnife stereotactic radiosurgery has on tumors near the critical structures of the eye (optic apparatus). The investigators hy...
Detailed Description
The CyberKnife system is a type of radiation machine that uses a special system to precisely focus large doses of x-rays (radiation) on the tumor. The device is designed to concentrate large doses of ...
Eligibility Criteria
Inclusion
- Perioptic lesion within 2mm of the optic apparatus
- Age \>= 21
- KPS \>= 50
- Planning Target Volume (PTV) \<= 6.0 cm in maximal diameter
Exclusion
- Malignant histology
- Age \< 21
- KPS \<= 40
- Planning Target Volume (PTV) \> 6.0 cm in maximal diameter
- Prior whole brain XRT
- Gross total resection
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2017
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT02225197
Start Date
December 1 2007
End Date
October 1 2017
Last Update
July 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Community Cancer Center
Normal, Illinois, United States, 61761